Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1983-4-15
|
pubmed:abstractText |
The hypotensive effect of short-term labetalol, the alpha- and beta-adrenoceptor blocker, is greater in subjects in the orthostatic position, possibly because of the alpha-adrenoceptor blockade. During prolonged use the orthostatic blood pressure fall disappears. To verify whether or not this is due to reduction in alpha-blocking activity, phenylephrine-induced increase in blood pressure was studied in six subjects with mild essential hypertension before and after 3 and 6 days and 1 and 6 mo of continuous treatment with 200 mg labetalol three times a day by mouth. At the same intervals, isoproterenol-induced tachycardia was followed to assess beta-blockade. After 3 days on labetalol, the log dose-response curve of phenylephrine-induced increase in blood pressure shifted to the right and the dose of agonist required to elicit a 20% increase in systolic pressure was 1.7 times that before treatment. There was a progressive decline in the dose of agonist that induced the same increase in pressure so that after 6 mo of continuous labetalol it was the same as control. In contrast, the amount of isoproterenol needed to induce a 20% increase in heart rate was two to three times that before labetalol and did not change throughout 6 mo of therapy. These data indicate a decline in the alpha-adrenoceptor-blocking effect of oral labetalol without concomitant change in the degree of beta-adrenoceptor blockade. This might account for the disappearance of orthostatic hypotension early in the course of treatment and for some decrease in the antihypertensive efficacy of labetalol.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Ethanolamines,
http://linkedlifedata.com/resource/pubmed/chemical/Isoproterenol,
http://linkedlifedata.com/resource/pubmed/chemical/Labetalol,
http://linkedlifedata.com/resource/pubmed/chemical/Phenylephrine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0009-9236
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
278-82
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6130864-Adrenergic alpha-Antagonists,
pubmed-meshheading:6130864-Adult,
pubmed-meshheading:6130864-Blood Pressure,
pubmed-meshheading:6130864-Dose-Response Relationship, Drug,
pubmed-meshheading:6130864-Ethanolamines,
pubmed-meshheading:6130864-Female,
pubmed-meshheading:6130864-Heart Rate,
pubmed-meshheading:6130864-Humans,
pubmed-meshheading:6130864-Hypertension,
pubmed-meshheading:6130864-Isoproterenol,
pubmed-meshheading:6130864-Labetalol,
pubmed-meshheading:6130864-Male,
pubmed-meshheading:6130864-Middle Aged,
pubmed-meshheading:6130864-Phenylephrine
|
pubmed:year |
1983
|
pubmed:articleTitle |
Alpha-adrenoceptor blockade by labetalol during long-term dosing.
|
pubmed:publicationType |
Journal Article
|